PhaseBio Pharmaceuticals Inc — Form D

PhaseBio Pharmaceuticals Inc of Malvern, PA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-31. The offering totals $7.9M, of which $6.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Ashutosh ChilkotiDirectorDurham, NC
Michael K GutchDirectorResearch Triangle Park, NC
Clay ThorpDirectorDurham, NC
Ashutosh ChilkotiExecutive OfficerDurham, NC
Jonathan MowDirectorEl Cajon, CA
Jonathan MowExecutive OfficerEl Cajon, CA
Tyrell RiversDirectorChicago, IL
Justin KleinDirectorSan Carlos, CA
Linda TuftsDirectorCleveland, OH
Christopher PriorDirectorRaleigh, NC
Christopher PriorExecutive OfficerRaleigh, NC
Bibhash MukhopadhyayDirectorMalvern, PA
John SharpExecutive OfficerMalvern, PA
Nancy HutsonDirectorMalvern, PA
Caroline LoewyDirectorMalvern, PA
Joel SussmanExecutive OfficerMalvern, PA
Thomas K LaundonDirectorResearch Triangle Park, NC
Thomas K LaundonExecutive OfficerResearch Triangle Park, NC
Douglas K ReedDirectorDurham, NC
Craig K RosenDirectorPasadena, MD
Justin K KleinDirectorChevy Chase, MD
Guy K FishDirectorBoston, MA
Asish K XavierDirectorNew Brunswick, NJ
James K BarrettDirectorBaltimore, MD
Robert K IngramDirectorDurham, NC

Other filings by this issuer (7)

FiledFormOfferingSold
2018-09-10D$32.1M$26.0M
2015-07-21D/A$42.0M$21.0M
2015-03-12D$40.0M$20.0M
2012-06-18D/A$48.5M$48.5M
2010-12-06D/A$25.3M$25.3M
2010-01-05D$25.3M$10.1M
2009-11-12D$1.0M$1000K

More